The Valley Desk

NCT02963935 · Interventional trial

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

Overall registry status Completed

Phase 3

Conditions Metabolism and Nutrition Disorder, Obesity

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov